Physicians' perceived usefulness of and satisfaction with test reports for cystic fibrosis (DeltaF508) and factor V Leiden

Genet Med. 2003 May-Jun;5(3):166-71. doi: 10.1097/01.GIM.0000066797.05220.85.

Abstract

Purpose: We sought to determine whether variation in test-report content for cystic fibrosis (CF DeltaF508) and factor V Leiden (fVL) would impact physician-perceived usefulness of and satisfaction with test reports.

Methods: A cross-sectional survey of US physicians from specialties likely to order the tests was performed. Physicians received an introductory letter with a clinical scenario, one randomly assigned mock report, and a one-page survey. The analyses evaluated usefulness of and satisfaction with report elements.

Results: For CF and fVL, there were significant differences by mock-report version for most of the survey report items (P < 0.05) and for satisfaction (P < 0.0001); results revealed greater usefulness and satisfaction with more comprehensive reports. The three items in CF and fVL reports where physician-perceived usefulness was most highly correlated (R > 0.70) with satisfaction were (1.clinical decision-making information, (2). genetic counseling information, and (3). implications for family members.

Conclusion: Opportunities exist to improve the usefulness of genetic test reports in clinical practice.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Attitude of Health Personnel*
  • Cross-Sectional Studies
  • Cystic Fibrosis / diagnosis
  • Cystic Fibrosis / genetics*
  • Cystic Fibrosis / therapy
  • Factor V / genetics*
  • Genetic Services*
  • Humans
  • Physicians

Substances

  • factor V Leiden
  • Factor V